Pharma's Role in Remote Patient Monitoring in Oncology

Remote patient monitoring (RPM) is a key component of digital health, especially in the field of oncology. Its applications in improving patient outcomes, reducing healthcare costs, and enhancing clinical trials are well-documented and growing. But how can the pharmaceutical industry engage with this emerging field to deliver substantive value to end users?

Register for this roundtable discussion focused on identifying where and how pharma can leverage RPM technology. We will discuss: 

• How pharma can differentiate itself and create a competitive advantage with RPM solutions for oncology

• Strategies pharma can take when integrating RPM into the care pathways of oncology patients

• How and when pharma should collaborate with digital health developers to co-create RPM solutions tailored to oncology patients and providers? What does a truly strategic partnership look like?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.